These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The seroprevalence of parvovirus B19 antibody in blood donors at the National Blood Transfusion Center in Kinshasa. Chabo Byaene A, Kabututu ZP, Abou Rayia DM, El-Sokkary MMA. J Med Virol; 2020 Mar; 92(3):288-294. PubMed ID: 31646654 [Abstract] [Full Text] [Related]
3. Prevalence and genotypic characterization of Human Parvovirus B19 in children with measles- and rubella-like illness in Iran. Rezaei F, Sarshari B, Ghavami N, Meysami P, Shadab A, Salimi H, Mokhtari-Azad T. J Med Virol; 2016 Jun; 88(6):947-53. PubMed ID: 26538067 [Abstract] [Full Text] [Related]
4. Acute human parvovirus B-19 infection in hospitalized children: A serologic and molecular survey. Miron D, Luder A, Horovitz Y, Izkovitz A, Shizgreen I, Ben David E, Ohnona FS, Schlesinger Y. Pediatr Infect Dis J; 2006 Oct; 25(10):898-901. PubMed ID: 17006284 [Abstract] [Full Text] [Related]
5. Infection and immunity for human parvovirus B19 in patients with febrile exanthema. Pedranti MS, Barbero P, Wolff C, Ghietto LM, Zapata M, Adamo MP. Epidemiol Infect; 2012 Mar; 140(3):454-61. PubMed ID: 21676356 [Abstract] [Full Text] [Related]
6. Detection of human parvovirus B19 in serum samples from children under 5 years of age with rash-fever illnesses in the Democratic Republic of the Congo. Wawina TB, Tshiani OM, Ahuka SM, Pukuta ES, Aloni MN, Kasanga CJ, Muyembe JT. Int J Infect Dis; 2017 Dec; 65():4-7. PubMed ID: 28951104 [Abstract] [Full Text] [Related]
7. Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs. Grosse-Bley A, Eis-Hübinger AM, Kaiser R, Oldenburg J, Brackmann HH, Schwarz TF, Schneweis KE. Thromb Haemost; 1994 Oct; 72(4):503-7. PubMed ID: 7878623 [Abstract] [Full Text] [Related]
8. Parvovirus B19 infection and kidney injury: report of 4 cases and analysis of immunization and viremia in an adult cohort of 100 patients undergoing a kidney biopsy. Kauffmann M, Bobot M, Daniel L, Torrents J, Knefati Y, Moranne O, Burtey S, Zandotti C, Jourde-Chiche N. BMC Nephrol; 2020 Jul 09; 21(1):260. PubMed ID: 32646497 [Abstract] [Full Text] [Related]
9. Human parvovirus B19 surveillance in patients with rash and fever from Belarus. Yermalovich MA, Hübschen JM, Semeiko GV, Samoilovich EO, Muller CP. J Med Virol; 2012 Jun 09; 84(6):973-8. PubMed ID: 22499021 [Abstract] [Full Text] [Related]
10. [Parvovirus B19 outbreak in a rural community in Alicante]. Martínez-Campillo F, López J, Verdú M, Andreu M, Rigo MV. Enferm Infecc Microbiol Clin; 2002 Oct 09; 20(8):376-9. PubMed ID: 12372232 [Abstract] [Full Text] [Related]
11. [Exanthematous outbreak caused by human parvovirus B19 in a school in Banderaló, Argentina]. Alonso A, Distefano A, Carlino O, Polito A. Rev Argent Microbiol; 2003 Oct 09; 35(3):171-4. PubMed ID: 14587381 [Abstract] [Full Text] [Related]
12. Insights into epidemiology of human parvovirus B19 and detection of an unusual genotype 2 variant, Bulgaria, 2004 to 2013. Ivanova SK, Mihneva ZG, Toshev AK, Kovaleva VP, Andonova LG, Muller CP, Hübschen JM. Euro Surveill; 2016 Oct 09; 21(4):. PubMed ID: 26847955 [Abstract] [Full Text] [Related]
13. Low prevalence of antibody to human parvovirus B19 in Singapore. Matsunaga Y, Goh KT, Utagawa E, Muroi N. Epidemiol Infect; 1994 Dec 09; 113(3):537-40. PubMed ID: 7995362 [Abstract] [Full Text] [Related]
14. Seroepidemiology of Human Parvovirus B19 Infection among the Population of Vojvodina, Serbia, over a 16-Year Period (2008-2023). Vuković V, Patić A, Ristić M, Kovačević G, Hrnjaković Cvjetković I, Petrović V. Viruses; 2024 Jan 25; 16(2):. PubMed ID: 38399956 [Abstract] [Full Text] [Related]
15. Clinical and epidemiological aspects of human parvovirus B19 infection in an urban area in Brazil (Niterói city area, State of Rio de Janeiro, Brazil). Oliveira SA, Camacho LA, Pereira AC, Faillace TF, Setubal S, Nascimento JP. Mem Inst Oswaldo Cruz; 2002 Oct 25; 97(7):965-70. PubMed ID: 12471422 [Abstract] [Full Text] [Related]
16. Identification of human parvovirus B19 among measles and rubella suspected patients from Cuba. de Los Ángeles Ribas M, Tejero Y, Cordero Y, Pérez D, Sausy A, Muller CP, Hübschen JM. J Med Virol; 2019 Jul 25; 91(7):1351-1354. PubMed ID: 30817853 [Abstract] [Full Text] [Related]
17. When a viral eruption hides another one: intrafamilial outbreak of parvovirus B19 and measles virus co-infections: case report. Grolhier C, Pronier C, Belem A, Dina J, Vabret A, Grau JA, Tattevin P, Thibault V. BMC Infect Dis; 2020 Jul 11; 20(1):496. PubMed ID: 32652942 [Abstract] [Full Text] [Related]
18. Parvovirus infection in children with AIDS: high prevalence of B19-specific immunoglobulin M and G antibodies. Nigro G, Luzi G, Fridell E, Ferrara M, Pisano P, Gattinara GC, Mezzaroma I, Söderlund M, Rasnoveanu D, Aiuti F. AIDS; 1992 Jul 11; 6(7):679-84. PubMed ID: 1503687 [Abstract] [Full Text] [Related]
19. [The use of real-time polymerase chain reaction and enzyme immunoassay for the diagnosis of acute parvovirus B19 infections in immunosuppressed patients]. Işik N, Ağaçfidan A, Ağirbaşli H, Işik DM, Bozkaya E, Gedikoğlu G, Badur S. Mikrobiyol Bul; 2003 Oct 11; 37(4):277-83. PubMed ID: 14748265 [Abstract] [Full Text] [Related]
20. A significant age shift of the human parvovirus B19 antibody prevalence among young adults in Japan observed in a decade. Yamashita K, Matsunaga Y, Taylor-Wiedeman J, Yamazaki S. Jpn J Med Sci Biol; 1992 Apr 11; 45(2):49-58. PubMed ID: 1434067 [Abstract] [Full Text] [Related] Page: [Next] [New Search]